Sfoglia per Autore "Pontikides, N."
Items 1-3 di 3
-
Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome
Kaltsas, T.; Pontikides, N.; Krassas, G. E.; Seferiadis, K.; Lolis, D.; Messinis, I. E. (1998)The suppression of the pituitary-gonadal axis by the administration of gonadotrophin-releasing hormone agonists (GnRH-a) is used occasionally as an adjunct therapy with gonadotrophins for ovulation induction in women with ... -
Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome
Kaltsas, T.; Pontikides, N.; Krassas, G. E.; Seferiadis, K.; Lolis, D.; Messinis, I. E. (1999)Recent clinical studies have suggested that women with polycystic ovarian syndrome (PCOS) may have disturbances of growth hormone (GH) kinetics and the GH/insulin-like growth factor (IGF)-I system. The knowledge that in ... -
Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide
Krassas, G. E.; Kaltsas, T. T.; Pontikides, N.; Jacobs, H.; Blum, W.; Messinis, I. (1998)Leptin, a product of the ob gene, is a 16 kDa protein which is produced by adipocytes. In humans, obesity is a common finding in women with polycystic ovary syndrome (PCOS). The role, however, of leptin in PCOS is not clear ...